Clinical application of DNA ploidy to cervical cancer screening: A review

Table 14 Crude cancer prevalence and other data from 36 published DNA Cytometry studies from China, 2005-2013

Ref.	Invasive cancer cases	CIN2+ cases	Total screened	Crude cancer prevalence (per 100000 persons)	Crude CIN2+ prevalence (%)	Follow-up ratio	Ca/CIN2+ (× 10)
[110]	3	14	500	600	2.8		2.14
[82]	7	100	23698	29.5	0.42	0.38	0.7
[111]	48	103	4020	1194	2.56	0.78	4.66
[112]	1	22	1200	83.3	1.83		0.45
[113]	2	17	673	297.2	2.53		1.18
[114]	4	12	3551	112.6	0.34		3.33
[115]	2	15	3162	63.3	0.47	0.39	1.33
[116]	14	78	4109	340.7	1.9	0.93	1.79
[117]	4	84	9261	43.2	0.91	0.36	0.48
[118]	2	30	2599	77	1.15		0.67
[119]	3	65	1200	250	5.42		0.46
[120]	9	111	6793	132.5	1.63	1	0.81
[121]	0	16	2003	0	0.8		0
[122]	4	87	2153	185.8	4.04		0.46
[123]	3	56	12079	24.8	0.46		0.54
[124]	5	26	3000	166.7	0.87		1.92
[125]	8	142	5886	135.9	2.41	1	0.56
[126]	11	147	7735	142.2	1.9	1	0.75
[127]	1	41	4598	21.7	0.89		0.24
[128]	4	34	12278	32.6	0.28		1.18
[129]	2	11	3589	55.7	0.31		1.82
[130]	3	17	1806	166.1	0.94		1.76
[131]	0	10	1206	0	0.83		0
[132]	8	51	3603	222	1.42	1	1.57
[133]	106	168	23993	441.8	0.7		6.31
[134]	6	36	1220	491.8	2.95		1.67
[76]	15	124	19621	76.4	0.63		1.21
[55]	2	21	3070	65.1	0.68		0.95
[135]	1	15	2000	50	0.75		0.67
[136]	0	5	1256	0	0.4		0
[137]	30	172	18097	165.8	0.95		1.74
[138]	1	7	451	221.7	1.55		1.43
[139]	10	53	430	2325.6	12.33		1.89
[140]	6	12	2832	211.9	0.42		5
[141]	15	95	8670	173	1.1		1.58
[142]	30	187	22169	135.3	0.84		1.6

CIN2+: Cervical intraepithelial neoplasia, grade 2 or higher.